Michael Riedel

Michael Riedel is a seasoned Business Development Manager with a focus on the pharmaceutical and biotechnology industries, specializing in delivering solutions for Cell & Gene Therapy.

He serves as the main point of contact for Lonza's Cell & Gene Therapy portfolio in EMEA, aiming to provide turnkey solutions and comprehensive services to customers.

With a doctorate degree in molecular biology, Michael is a stem/iPS cell specialist with extensive experience in this field, bringing a deep understanding of current challenges in the cell and gene therapies market.

His expertise extends to developing proposals and manufacturing contracts for the GMP manufacture of cell and gene therapies, along with managing global cross-functional teams as an experienced program/project manager.

Having held various roles in esteemed organizations like Lonza, Medical College of Wisconsin, University of Utah, and Harvard Stem Cell Institute, Michael Riedel has demonstrated a commitment to excellence and innovation in his professional journey.

He possesses an energetic and creative personality, coupled with strong interpersonal skills and a drive to achieve set goals.